Filing Details
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event.
8k filedNASDAQ:BJDX
Bluejay Diagnostics, Inc. (BJDX) Reports Material Event to SEC
Filing Details Bluejay Diagnostics, Inc. (NASDAQ:BJDX) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event. Market Context…
Market Context
Bluejay Diagnostics, Inc.'s stock currently trades at $1.15 with a market capitalization of $1.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Bluejay Diagnostics, Inc.'s stock.
All SEC filings for Bluejay Diagnostics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BJDX Stock Page
Frequently Asked Questions
Where can I read BJDX's SEC filings?
Browse all filings on our BJDX SEC filings page.
What types of SEC filings does Bluejay Diagnostics, Inc. file?
Public companies like Bluejay Diagnostics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
